A drug approved by the Food and Drug Administration for melanoma in combination with a common cholesterol-lowering drug may show promise in controlling cancer growth in patients with non-small cell lung cancer (NSCLC), according to new research from th…
Category: News
ST Asia signs licensing deal with PharmaMar to distribute new multiple myeloma drug in South East Asia
International biopharmaceutical company Specialised Therapeutics Asia will supply and distribute a novel oncology drug candidate throughout South East Asia, following an exclusive licensing deal with European pharmaceutical company PharmaMar.
Mount Sinai researchers report new method to restore microbiome of newborns delivered via C-section
Scientists from the Icahn Institute for Genomics and Multiscale Biology at the Icahn School of Medicine at Mount Sinai, collaborating with NYU Langone Medical Center and a multi-center team of researchers, demonstrated for the first time that the micro…
Blue Light From Screens, Bulbs Won’t Damage Retina
Despite concerns that staring at devices putting out high amounts of the blue light wavelength could damage human retinas, a recent study finds that most devices put out less of that light than the blue sky on a clear day. Reuters Health Information
Technavio Announces the Top Three Emerging Trends Impacting the Global Iris Recognition Market Through 2020
LONDON–(BUSINESS WIRE)–Technavio’s latest report on global iris recognition market provides an analysis of the key trends expected to impact the global iris recognition market across 2016-2020.
Undisclosed Conflicts Common Among FDA Hearing Speakers
(MedPage Today) — “Industry has hijacked the microphone”
Reforming Federal Oversight of Medical Devices Won’t Be Easy
(MedPage Today) — Implementing a new system could take years
World Vision Care Medical Devices Pipeline Assessment 2015-2016 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/tnf5f8/vision_care) has announced the addition of the “Vision Care – Medical Devices Pipeline Assessment, 2015” report to their offering. The report provides comp…
Inotek Pharmaceuticals Announces Participation in Ophthalmology Panel at 18th Annual BIO CEO & Investor Conference on February 8th
LEXINGTON, Mass.–(BUSINESS WIRE)–Inotek announced that David P. Southwell, President and Chief Executive Officer, will participate in an ophthalmology panel at the 18th Annual BIO CEO & Investor Conference.
Coming to Atlanta – Eye Exams at the Office!
BOSTON–(BUSINESS WIRE)–For today’s workforce, it’s hard to squeeze in important medical appointments, and in general, find that elusive work-life balance. According to the Center for Disease Control and Prevention, an estimated 61 million adults in the US are at risk for vision loss, yet only half had gone to the eye doctor in the previous 12 months. New this spring, Atlanta employers can help make getting an eye exam faster and easier for their employees. Why make thousands of people commute
Glaukos Launches New Direct Sales Organization and Begins Commercialization of iStent inject® Trabecular Micro-Bypass Stent in Canada
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that it has created a direct sales organization and initiated the commercial launch of the iStent inject® Trabecular Micro-Bypass Stent in Canada. The iStent inject system is preloaded with two micro-scale stents that the surgeon p
HOYA Group Appoints Gerald W. Bottero Global President of PENTAX Medical
TOKYO–(BUSINESS WIRE)–PENTAX Medical, a division of HOYA Group, has announced the appointment of Gerald W. Bottero to the position of Global President of PENTAX Medical as of February 1st, 2016.
PENTAX Medical事業部長にジェラルド・W. ボッテロ が就任
東京–(BUSINESS WIRE)–（ビジネスワイヤ） — HOYAグループPENTAX Medical事業部はこのたび、2016年2月1日付でジェラルド・W. ボッテロが医療用内視鏡の製造・販売を行うPENTAX Medical事業部長に就任したことを発表します。 HOYA株式会社 代表執行役最高経営責任者 (CEO)である鈴木 洋は、ボッテロの事業部長就任にあたり「ボッテロをPENTAX Medical事業のグローバルリーダーとして迎えることができ、大変うれしく思います。ＨＯＹＡグループでの様々な要職を経て彼が得た豊富な見識と経験、リーダーシップは、PENTAX Medicalのグローバルな成長への大きな推進力となると確信しています。」と述べています。 ボッテロは1989年にHOYA株式会社に入社後、様々な事業に携わってきました。直近では、2005年まではHOYA Conbio（皮膚科/歯科用レーザー治療機器）、Decibel Instruments（補聴器）、Lifespex, Inc.（子宮頸がんの早期発見ソリューション）で取締役を、そして2005年4月から2014年
California Voters Will Have Their Say on Drug Prices
(MedPage Today) — Measure would require state to bargain harder with drug companies
D.C. Week: Senator Places Hold on Califf’s FDA Nomination
(MedPage Today) — Breast cancer drug gains approval for liposarcoma
RegeneRx Biopharmaceuticals announces completion of enrollment for Phase 2b/3 dry eye trial in U.S.
RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that its U.S. joint venture with G-treeBNT, ReGenTree LLC, has completed enrollment of its Phase 2b/3 dr…
Brain’s natural plasticity could compensate for inner ear damage
Researchers from Massachusetts Eye and Ear/Harvard Medical School have described, for the first time, the adult brain’s ability to compensate for a near-complete loss of auditory nerve fibers that link the ear to the brain. The findings, published in t…
MyOptique Group Named a Bloomberg Business Innovator 2016
LONDON–(BUSINESS WIRE)–Bloomberg has unveiled its inaugural Bloomberg Business Innovators list, naming MyOptique Group as one of the breakthrough businesses disrupting the way people live, work and think in the UK.
Macular Edema – Pipeline Review 2015 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/9fzv2r/macular_edema) has announced the addition of the “Macular Edema – Pipeline Review, H2 2015” report to their offering. This report provides comprehensive in…
Joseph F. Bruno Named President and Chief Executive Officer of Helen Keller Services
BROOKLYN, N.Y.–(BUSINESS WIRE)–Former NYC OEM Commissioner Joseph F. Bruno named President/CEO of Helen Keller Services (HKS), a national organization founded in 1893. Bruno has been an active board trustee for over 16 years.